The store will not work correctly when cookies are disabled.
5'-phenyl-3'H-4-azaspiro[bicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridine]
ID: ALA189861
PubChem CID: 10085732
Max Phase: Preclinical
Molecular Formula: C19H20N2O
Molecular Weight: 292.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(-c2cnc3c(c2)CC2(CN4CCC2CC4)O3)cc1
Standard InChI: InChI=1S/C19H20N2O/c1-2-4-14(5-3-1)16-10-15-11-19(22-18(15)20-12-16)13-21-8-6-17(19)7-9-21/h1-5,10,12,17H,6-9,11,13H2
Standard InChI Key: GIRLVGYIIVFTLI-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 26 0 0 0 0 0 0 0 0999 V2000
2.8042 -0.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1000 0.5333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9167 0.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1375 -0.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5000 1.0708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4417 -0.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5292 -0.3375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3750 -0.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9292 -0.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5167 0.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9750 0.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3042 0.8583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3167 -0.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9667 0.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0542 -0.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6417 -0.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5292 0.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5250 -0.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8917 0.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6917 0.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3167 -1.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9042 -0.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 6 1 0
5 3 1 0
6 1 1 0
7 8 1 0
8 1 1 0
9 4 1 0
10 9 2 0
11 1 1 0
12 5 2 0
13 10 1 0
14 11 1 0
15 11 1 0
16 15 1 0
17 14 1 0
18 13 2 0
19 13 1 0
20 19 2 0
21 18 1 0
22 20 1 0
4 3 2 0
7 16 1 0
17 7 1 0
12 10 1 0
22 21 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.38 | Molecular Weight (Monoisotopic): 292.1576 | AlogP: 3.15 | #Rotatable Bonds: 1 |
Polar Surface Area: 25.36 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.36 | CX LogP: 3.18 | CX LogD: 2.18 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.81 | Np Likeness Score: 0.40 |
References
1. Jensen AA, Frølund B, Liljefors T, Krogsgaard-Larsen P.. (2005) Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations., 48 (15): [PMID:16033252] [10.1021/jm040219e] |